Brief: Kancera Meets Primary Objectives Of Kand145 Clinical Phase I Study

Novakand Pharma AB

03/05/2024 07:42

May 3 (Reuters) - Kancera AB  KANC.ST :
    * KANCERA MEETS THE PRIMARY OBJECTIVES OF THE KAND145
CLINICAL
PHASE I STUDY
    * REPORTS POSITIVE RESULTS FROM CLINICAL PHASE I STUDY WITH
KAND145 IN HEALTHY SUBJECTS AND THAT PRIMARY OBJECTIVES

Source text for Eikon:  ID:nMFN69d2ZP 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))